{{Rsnum
|rsid=4591494
|Chromosome=3
|position=7941140
|Orientation=plus
|GMAF=0.275
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 38.1 | 57.5
| HCB | 18.4 | 53.7 | 27.9
| JPT | 17.7 | 47.8 | 34.5
| YRI | 0.0 | 13.0 | 87.0
| ASW | 3.5 | 8.8 | 87.7
| CHB | 18.4 | 53.7 | 27.9
| CHD | 18.3 | 52.3 | 29.4
| GIH | 2.0 | 25.7 | 72.3
| LWK | 0.0 | 22.7 | 77.3
| MEX | 10.3 | 51.7 | 37.9
| MKK | 0.0 | 14.8 | 85.2
| TSI | 3.9 | 27.5 | 68.6
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs4591494
|PubMedID=17903294
|Condition=Factor VII
|Gene=Intergenic
|Risk Allele=
|pValue=9.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs4591494
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903294; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study (Initial Sample Size: 1,000 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Factor VII.
|Drugs=
|Drug Classes=
|Diseases=Hematologic Diseases
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356458
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4591494
|overall_frequency_n=19
|overall_frequency_d=128
|overall_frequency=0.148438
|n_genomes=16
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}